DOSSIER · 13F Holders · Q1 2026Healthcare · Pharmaceutical Preparations
APLS
APELLIS PHARMACEUTICALS INC
60 institutions still hold APELLIS PHARMACEUTICALS INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 03753U106·Pharmaceutical Preparations·60 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
60 institutions reported APLS in Q1 2026. Point72 Asset Management, L.P. leads at 28.3% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 3
40 more holders available. Log in →